Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection

British Journal of Surgery

Volumn 99, Issue 4, 2012, Pages 558-565

  Evrard, S ^a,c   Rivoire, M ^f   Arnaud, J P ^g   Lermite, E ^g   Bellera, C ^b,e   Fonck, M ^a   Becouarn, Y ^a   Lalet, C ^b   Pulido, M ^b,d   Mathoulin Pelissier, S ^b,c,e  

^a INSTITUT BERGONIÉ   (France)

^b Clinical and Epidemiological Research Unit   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INSTITUT NATIONAL DU CANCER   (France)

^e Centre of Clinical Investigation Clinical Epidemiology   (France)

^f CENTRE LÉON BÉRARD   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858075200     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8665     Document Type: Article

References (28)

1. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al., Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 2010; 11: 38-47.
2. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, et al., Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006; 10: 86-94. (Pubitemid 41820593)
3. Cady B, Stone MD, McDermott WV Jr, Jenkins RL, Bothe A Jr, Lavin PT, et al., Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992; 127: 561-568.
4. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al., Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002; 137: 833-840. (Pubitemid 34743176)
5. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R,. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 2008; 248: 626-637.
6. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al., High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011; 29: 1083-1090.
7. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, et al., Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8. (Pubitemid 30190357)
8. Elias D, Goharin A, El Otmany A, Taieb J, Duvillard P, Lasser P, et al., Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 2000; 26: 763-769. (Pubitemid 32059834)
9. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al., Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Data validation in an economic evaluation of surgery for colon cancer. Ann Surg 2004; 239: 818-825.
10. Curley SA,. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 2008; 15: 11-13.
11. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D,. Randomised trials in surgery: problems and possible solutions. BMJ 2002; 324: 1448-1451. (Pubitemid 34634244)
12. Ruers T, Punt CJ, van Coevorden F, Borel, Rinkes I, Ledermann JA, Poston GJ, et al., Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). J Clin Oncol 2010; 28 (Suppl): 712s (abstract 10057).
13. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD III, Dorfman GS, et al., American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508.
14. Simon R,. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10: 1-10. (Pubitemid 19099520)
15. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213. (Pubitemid 38963009)
16. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L,. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171. (Pubitemid 41033431)
17. Abitabile P, Hartl U, Lange J, Maurer CA,. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 2007; 33: 67-71. (Pubitemid 46131881)
18. Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pélissier S, Evrard S,. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol 2008; 34: 185-190.
19. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P,. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004; 11: 500-505. (Pubitemid 40486731)
20. Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S,. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006; 139: 263-273. (Pubitemid 43170328)
21. Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD, Pawlik TM,. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143: 1204-1212.
22. Meredith K, Haemmerich D, Qi C, Mahvi D,. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg 2007; 245: 771-776. (Pubitemid 46684107)
23. von Breitenbuch P, Köhl G, Guba M, Geissler E, Jauch KW, Steinbauer M,. Thermoablation of colorectal liver metastases promotes proliferation of residual intrahepatic neoplastic cells. Surgery 2005; 138: 882-887. (Pubitemid 41608483)
24. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al., Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016. (Pubitemid 351392040)
25. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, Paule B, et al., Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009; 27: 1829-1835.
26. de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, et al., Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2010; 15: 336-344.
27. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al., Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072. (Pubitemid 46622116)
28. Elias D, Baton O, Sideris L, Boige V, Malka D, Liberale G, et al., Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 2005; 90: 36-42. (Pubitemid 40446473)